
Acorda Therapeutics ACOR
Quarterly report 2024-Q1
added 05-16-2026
Acorda Therapeutics P/S Ratio 2011-2026 | ACOR
Annual P/S Ratio Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.142 | 0.115 | 0.152 | 0.356 | 0.502 | 67.8 | 12.2 | 10.7 | 18.9 | 25.6 | 21 | 22.4 | 20.4 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 67.8 | 0.115 | 15.4 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 92.7 | 0.61 % | $ 22.4 B | ||
|
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Compugen Ltd.
CGEN
|
2.7 | $ 2.66 | -5.12 % | $ 249 M | ||
|
Abcam plc
ABCM
|
13.7 | - | - | $ 4.9 B | ||
|
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | ||
|
Affimed N.V.
AFMD
|
13.1 | - | -34.95 % | $ 21.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Celyad Oncology SA
CYAD
|
21.3 K | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
30.3 | - | - | $ 344 M | ||
|
IMV
IMV
|
48.2 | - | - | $ 13.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
2.54 | - | -4.36 % | $ 27 M | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.63 | 1.24 % | $ 191 M | ||
|
Anika Therapeutics
ANIK
|
1.9 | $ 14.82 | -0.4 % | $ 213 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
41.6 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.45 | 1.5 % | $ 5.68 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.5 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 21.14 | 1.34 % | $ 2.69 B | ||
|
Ampio Pharmaceuticals
AMPE
|
236 | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B |